ATTRUVIQ

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ATTRUVIQ was filed as Word mark on 08/18/2022 at the World Intellectual Property Organization.

Trademark Details Last update: August 4, 2023

Trademark form Word mark
File reference 1684845
Countries United Arab Emirates Australia Brazil Canada Switzerland Chile China Colombia European Community United Kingdom Israel India Japan South Korea Mexico Norway New Zealand Singapore Turkey
Base trademark US No. 97288152, February 28, 2022
Application date August 18, 2022
Expiration date August 18, 2032

Trademark owner

421 Kipling Street
Palo Alto CA 94301
US

Trademark representatives

620 Eighth Avenue New York NY 10018 US

goods and services

05 Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders

Trademark history

Date Document number Area Entry
August 2, 2023 2023/31 Gaz CH Rejection
June 4, 2023 2023/23 Gaz IL Rejection
May 9, 2023 2023/19 Gaz CL Rejection
March 6, 2023 2023/10 Gaz CN Rejection
February 21, 2023 2023/8 Gaz NZ Rejection
February 8, 2023 2023/6 Gaz EM Rejection
December 21, 2022 2022/51 Gaz GB Rejection
December 20, 2022 2023/1 Gaz US Correction
December 20, 2022 2022/51 Gaz TR Rejection
December 15, 2022 2022/50 Gaz AU Rejection
August 18, 2022 2022/36 Gaz US Registration

ID: 141684845